Barely Significant
← all excerpts

A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression.

Pharmaceuticals (Basel) · 2021 · PMC8706080 · PMID 34959723

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

did not achieve significancep = 0.07so close (0.05 < p ≤ 0.1)
The log-rank (Mantel–Cox) test, which places equal weight on all time points, trended toward significant differences in survival probability but did not achieve significance ( p = 0.07).

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.